Search research articles
Contact Us
Filters
Showing results (1-10 of 6) with videos related to
Page
of 1
Sort By:
Applied Biosafety : Journal of the American Biological Safety Association
|
August 29, 2022
Validating Autoclave Cycles for Carcass Disposal in Animal Biosafety Level 2/3 Containment Laboratories
Rebecca McGirr, Christopher Sample, Leslee Arwood, et al.
Journal of Dentistry
|
June 20, 2022
Efficacy and hazards of 425 nm oral cavity light dosing to inactivate SARS-CoV-2
Max A Stockslager, Jacob F Kocher, Leslee Arwood, et al.
Biorxiv : the Preprint Server for Biology
|
February 8, 2022
Visible blue light inactivates SARS-CoV-2 variants and inhibits Delta replication in differentiated human airway epithelia
Jacob Kocher, Leslee Arwood, Rachel C Roberts, et al.
Msphere
|
May 28, 2025
The pan-variant potential of light: 425 nm light inactivates SARS-CoV-2 variants of concern and non-cytotoxic doses reduce viral titers in human airway epithelial cells
Nathan Stasko, Leslee Arwood, Nicole Jandick, et al.
Scientific Reports
|
October 19, 2021
Visible blue light inhibits infection and replication of SARS-CoV-2 at doses that are well-tolerated by human respiratory tissue
Nathan Stasko, Jacob F Kocher, Abigail Annas, et al.
Immunity
|
August 14, 2020
A Single Immunization with Nucleoside-Modified mRNA Vaccines Elicits Strong Cellular and Humoral Immune Responses against SARS-CoV-2 in Mice
Dorottya Laczkó, Michael J Hogan, Sushila A Toulmin, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 6) with videos related to
Sort By:
Page
of 1
Applied Biosafety : Journal of the American Biological Safety Association
|
August 29, 2022
Validating Autoclave Cycles for Carcass Disposal in Animal Biosafety Level 2/3 Containment Laboratories
Rebecca McGirr, Christopher Sample, Leslee Arwood, et al.
Journal of Dentistry
|
June 20, 2022
Efficacy and hazards of 425 nm oral cavity light dosing to inactivate SARS-CoV-2
Max A Stockslager, Jacob F Kocher, Leslee Arwood, et al.
Biorxiv : the Preprint Server for Biology
|
February 8, 2022
Visible blue light inactivates SARS-CoV-2 variants and inhibits Delta replication in differentiated human airway epithelia
Jacob Kocher, Leslee Arwood, Rachel C Roberts, et al.
Msphere
|
May 28, 2025
The pan-variant potential of light: 425 nm light inactivates SARS-CoV-2 variants of concern and non-cytotoxic doses reduce viral titers in human airway epithelial cells
Nathan Stasko, Leslee Arwood, Nicole Jandick, et al.
Scientific Reports
|
October 19, 2021
Visible blue light inhibits infection and replication of SARS-CoV-2 at doses that are well-tolerated by human respiratory tissue
Nathan Stasko, Jacob F Kocher, Abigail Annas, et al.
Immunity
|
August 14, 2020
A Single Immunization with Nucleoside-Modified mRNA Vaccines Elicits Strong Cellular and Humoral Immune Responses against SARS-CoV-2 in Mice
Dorottya Laczkó, Michael J Hogan, Sushila A Toulmin, et al.
Page
of 1